A randomized, double-blind, placebo-controlled trial of hydrocortisone augmentation of Prolonged Exposure for PTSD in U.S. combat veterans

CONCLUSIONS: Treatment matching based on cognitive or biological vulnerabilities might lead to greater efficacy of PE with glucocorticoid augmentation.PMID:34298438 | DOI:10.1016/j.brat.2021.103924

Source: Behaviour Research and Therapy - July 23, 2021 Category: Psychiatry & Psychology Authors: Amy Lehrner Tom Hildebrandt Linda M Bierer Janine D Flory Heather N Bader Iouri Makotkine Rachel Yehuda Source Type: research